atezolizumab,pembrolizumab,bevacizumab,sunitinib
merck,roche,pfizer
['atezo', 'renal,(-adrenal)', 'pembro']
the #oncoalerttoptweet day 2 #esmo22
tweet adj atezo does not show benefit over placebo in high risk renal cancer for dfs/os. no benefit even in m1 subgroup? this contrasts the pembro.
immotion150 saw atezo had a rr ~25% in advanced disease 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??